Milestone Pharmaceuticals...

NASDAQ: MIST · Real-Time Price · USD
1.95
0.01 (0.52%)
At close: Sep 18, 2025, 3:59 PM
1.94
-0.51%
After-hours: Sep 18, 2025, 07:41 PM EDT

Milestone Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
25.31M 13.76M 7.64M 114.14M
Short-Term Investments
44.38M 52.24M 56.95M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -2.68M -926K
Receivables
2.39M 3.85M 1.21M 483K
Inventory
n/a n/a -331K -356K
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
73.93M 73.03M 71.8M 118.92M
Property-Plant & Equipment
1.57M 2.19M 2.68M 926K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.57M 2.19M 2.68M 926K
Total Assets
75.5M 75.23M 74.48M 119.85M
Account Payables
1.93M 3.98M 2.26M 4.38M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
571K n/a 495K 224K
Other Current Liabilities
2.55M 1.99M 2.08M 1.23M
Total Current Liabilities
8.13M 7.23M 6.14M 6.78M
Long-Term Debt
53.35M 49.77M n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
54.23M 51.23M 2M 474K
Total Liabilities
62.35M 58.45M 8.13M 7.25M
Total Debt
54.8M 51.77M 2.49M 698K
Book Value
13.15M 16.77M 66.35M 112.6M
Book Value Per Share
0.21 0.39 1.56 2.69
Common Stock
288.05M 260.5M 273.9M 251.9M
Retained Earnings
-367.55M -326.03M -266.34M -206.32M
Comprehensive Income
53.08M 48.46M 34.35M -1.63M
Shareholders Equity
13.15M 16.77M 66.35M 112.6M
Total Investments
44.38M 52.24M 56.95M n/a